These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 17926340

  • 1. Modeling the hERG potassium channel in a phospholipid bilayer: Molecular dynamics and drug docking studies.
    Masetti M, Cavalli A, Recanatini M.
    J Comput Chem; 2008 Apr 15; 29(5):795-808. PubMed ID: 17926340
    [Abstract] [Full Text] [Related]

  • 2. Interaction simulation of hERG K+ channel with its specific BeKm-1 peptide: insights into the selectivity of molecular recognition.
    Yi H, Cao Z, Yin S, Dai C, Wu Y, Li W.
    J Proteome Res; 2007 Feb 15; 6(2):611-20. PubMed ID: 17269718
    [Abstract] [Full Text] [Related]

  • 3. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E, Lozinskaya IM, Lin Z, Semus SF, Blaney FE, Willette RN, Xu X.
    Mol Pharmacol; 2008 Mar 15; 73(3):639-51. PubMed ID: 18042732
    [Abstract] [Full Text] [Related]

  • 4. Toward a consensus model of the HERG potassium channel.
    Stary A, Wacker SJ, Boukharta L, Zachariae U, Karimi-Nejad Y, Aqvist J, Vriend G, de Groot BL.
    ChemMedChem; 2010 Mar 01; 5(3):455-67. PubMed ID: 20104563
    [Abstract] [Full Text] [Related]

  • 5. A novel structure-based virtual screening model for the hERG channel blockers.
    Du L, Li M, You Q, Xia L.
    Biochem Biophys Res Commun; 2007 Apr 20; 355(4):889-94. PubMed ID: 17331468
    [Abstract] [Full Text] [Related]

  • 6. Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach.
    Imai YN, Ryu S, Oiki S.
    J Med Chem; 2009 Mar 26; 52(6):1630-8. PubMed ID: 19260734
    [Abstract] [Full Text] [Related]

  • 7. Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.
    Zachariae U, Giordanetto F, Leach AG.
    J Med Chem; 2009 Jul 23; 52(14):4266-76. PubMed ID: 19534531
    [Abstract] [Full Text] [Related]

  • 8. Molecular dynamics and continuum electrostatics studies of inactivation in the HERG potassium channel.
    Kutteh R, Vandenberg JI, Kuyucak S.
    J Phys Chem B; 2007 Feb 08; 111(5):1090-8. PubMed ID: 17266262
    [Abstract] [Full Text] [Related]

  • 9. Refining insights into high-affinity drug binding to the human ether-à-go-go-related gene potassium channel.
    Hancox JC, James AF.
    Mol Pharmacol; 2008 Jun 08; 73(6):1592-5. PubMed ID: 18381562
    [Abstract] [Full Text] [Related]

  • 10. Combined receptor and ligand-based approach to the universal pharmacophore model development for studies of drug blockade to the hERG1 pore domain.
    Durdagi S, Duff HJ, Noskov SY.
    J Chem Inf Model; 2011 Feb 28; 51(2):463-74. PubMed ID: 21241063
    [Abstract] [Full Text] [Related]

  • 11. Computer simulations of structure-activity relationships for HERG channel blockers.
    Boukharta L, Keränen H, Stary-Weinzinger A, Wallin G, de Groot BL, Aqvist J.
    Biochemistry; 2011 Jul 12; 50(27):6146-56. PubMed ID: 21657256
    [Abstract] [Full Text] [Related]

  • 12. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies.
    Farid R, Day T, Friesner RA, Pearlstein RA.
    Bioorg Med Chem; 2006 May 01; 14(9):3160-73. PubMed ID: 16413785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insights for human ether-a-go-go-related gene potassium channel inhibition using recursive partitioning and Kohonen and Sammon mapping techniques.
    Ekins S, Balakin KV, Savchuk N, Ivanenkov Y.
    J Med Chem; 2006 Aug 24; 49(17):5059-71. PubMed ID: 16913696
    [Abstract] [Full Text] [Related]

  • 18. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T, Elcock AH.
    J Mol Biol; 2006 May 26; 359(1):202-14. PubMed ID: 16616932
    [Abstract] [Full Text] [Related]

  • 19. Quantitative structure-activity relationship studies on inhibition of HERG potassium channels.
    Yoshida K, Niwa T.
    J Chem Inf Model; 2006 May 26; 46(3):1371-8. PubMed ID: 16711756
    [Abstract] [Full Text] [Related]

  • 20. APETx1 from sea anemone Anthopleura elegantissima is a gating modifier peptide toxin of the human ether-a-go-go- related potassium channel.
    Zhang M, Liu XS, Diochot S, Lazdunski M, Tseng GN.
    Mol Pharmacol; 2007 Aug 26; 72(2):259-68. PubMed ID: 17473056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.